114 related articles for article (PubMed ID: 35818932)
21. Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.
Su Y; Huang N; Chen D; Zhang L; Dong X; Sun Y; Zhu X; Zhang F; Gao J; Wang Y; Fan K; Lo P; Li W; Ling C
Int J Nanomedicine; 2017; 12():4019-4035. PubMed ID: 28603416
[TBL] [Abstract][Full Text] [Related]
22. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Kutty RV; Feng SS
Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
[TBL] [Abstract][Full Text] [Related]
23. In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer.
Kutty RV; Chia SL; Setyawati MI; Muthu MS; Feng SS; Leong DT
Biomaterials; 2015 Sep; 63():58-69. PubMed ID: 26081868
[TBL] [Abstract][Full Text] [Related]
24. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
25. Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axis.
Chen Q; Han H; Lin F; Yang L; Feng L; Lai X; Wen Z; Yang M; Wang C; Ma Y; Yin T; Lu G; Lin H; Qi J; Yang Y
Life Sci; 2022 Dec; 310():121077. PubMed ID: 36244412
[TBL] [Abstract][Full Text] [Related]
26. Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.
Zhang Y; Zhou J; Yang C; Wang W; Chu L; Huang F; Liu Q; Deng L; Kong D; Liu J; Liu J
Int J Nanomedicine; 2016; 11():1119-30. PubMed ID: 27051287
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment.
Khondee S; Chittasupho C; Tima S; Anuchapreeda S
Curr Drug Deliv; 2018; 15(3):406-416. PubMed ID: 28707580
[TBL] [Abstract][Full Text] [Related]
28. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
29. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
Chen R; Ni S; Chen W; Liu M; Feng J; Hu K
Int J Nanomedicine; 2021; 16():5265-5279. PubMed ID: 34376979
[TBL] [Abstract][Full Text] [Related]
30. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
31. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
[TBL] [Abstract][Full Text] [Related]
32. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
Mi Y; Liu Y; Feng SS
Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707
[TBL] [Abstract][Full Text] [Related]
33. Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy.
Su YC; Burnouf PA; Chuang KH; Chen BM; Cheng TL; Roffler SR
Nat Commun; 2017 Jun; 8():15507. PubMed ID: 28593948
[TBL] [Abstract][Full Text] [Related]
34. Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer.
Paulmurugan R; Bhethanabotla R; Mishra K; Devulapally R; Foygel K; Sekar TV; Ananta JS; Massoud TF; Joy A
Mol Cancer Ther; 2016 Feb; 15(2):221-31. PubMed ID: 26553061
[TBL] [Abstract][Full Text] [Related]
35. Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
Zuo R; Zhang Y; Chen X; Hu S; Song X; Gao X; Gong J; Ji H; Yang F; Peng L; Fang K; Lv Y; Zhang J; Jiang S; Guo D
Int J Nanomedicine; 2022; 17():2475-2491. PubMed ID: 35668999
[TBL] [Abstract][Full Text] [Related]
36. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.
Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K
Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063
[TBL] [Abstract][Full Text] [Related]
37. Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer.
Dai W; Yang F; Ma L; Fan Y; He B; He Q; Wang X; Zhang H; Zhang Q
Biomaterials; 2014 Jul; 35(20):5347-5358. PubMed ID: 24726747
[TBL] [Abstract][Full Text] [Related]
38. A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer.
Wen H; Martínez MG; Happonen E; Qian J; Vallejo VG; Mendazona HJ; Jokivarsi K; Scaravilli M; Latonen L; Llop J; Lehto VP; Xu W
Int J Pharm; 2024 Mar; 652():123764. PubMed ID: 38176479
[TBL] [Abstract][Full Text] [Related]
39. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
40. Unlocking apoptosis in triple negative breast cancer: Harnessing "glutamine trap" to amplify the efficacy of lapatinib-loaded mixed micelles.
Ghadi R; Kuche K; Date T; Nallamothu B; Chaudhari D; Jain S
Biomater Adv; 2024 May; 159():213822. PubMed ID: 38442461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]